Annual Drug Patent Expirations for NUVIGIL
Nuvigil is a drug marketed by Cephalon and is included in one NDA. It is available from seven suppliers. There are two patents protecting this drug and two Paragraph IV challenges.
Drug patent litigation for NUVIGIL.
The generic ingredient in NUVIGIL is armodafinil. Seven suppliers are listed for this compound. Additional details are available on the armodafinil profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com